Benefit assessment of anti-ageing medicines in the European Union: regulatory obstacles and pluralistic alternatives.
- DOI
- 10.1007/s40656-026-00759-w
- Published
- 2026 Sep 25
- Container
- History and philosophy of the life sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40656-026-00759-w,
title = {Benefit assessment of anti-ageing medicines in the European Union: regulatory obstacles and pluralistic alternatives.},
author = {Marín Penella G and López-Mas R},
year = {2026},
journal = {History and philosophy of the life sciences},
doi = {10.1007/s40656-026-00759-w},
url = {https://doi.org/10.1007/s40656-026-00759-w}
}RIS
TY - JOUR TI - Benefit assessment of anti-ageing medicines in the European Union: regulatory obstacles and pluralistic alternatives. AU - Marín Penella G AU - López-Mas R PY - 2026 JO - History and philosophy of the life sciences DO - 10.1007/s40656-026-00759-w UR - https://doi.org/10.1007/s40656-026-00759-w ER -
APA
G, M. P., & R, L. (2026). Benefit assessment of anti-ageing medicines in the European Union: regulatory obstacles and pluralistic alternatives.. History and philosophy of the life sciences. https://doi.org/10.1007/s40656-026-00759-w
Source records
- pubmed · retrieved 2026-09-26T00:14:52.456Z